Molecular mapping of chromosome 2 deletions in murine radiation-induced AML localizes a putative tumor suppressor gene to a 1.0 cM region homologous to human chromosome segment 11 p 11-12

Genes Chromosomes and Cancer

Volumn 24, Issue 2, 1999, Pages 95-104

  Silver, Andrew ^a,d   Moody, John ^a   Dunford, Rosemary ^a   Clark, Debbie ^a,c   Ganz, Sue ^a   Bulman, Robert ^a   Bouffler, Simon ^a   Finnon, Paul ^a   Meijne, Emmy ^b   Huiskamp, Rene ^b   Cox, Roger ^a  

^a Radiation Effects Department   (United Kingdom)

^b TNO   (Netherlands)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTIG; MICROSATELLITE DNA; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 11; CHROMOSOME 2; CHROMOSOME DELETION; CHROMOSOME MAP; GENE MAPPING; HETEROZYGOSITY LOSS; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; TUMOR SUPPRESSOR GENE; YEAST ARTIFICIAL CHROMOSOME;

ANIMALS; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, ARTIFICIAL, YEAST; CHROMOSOMES, HUMAN, PAIR 11; CONTIG MAPPING; CROSSES, GENETIC; GENES, TUMOR SUPPRESSOR; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICROSATELLITE REPEATS; SEQUENCE HOMOLOGY, NUCLEIC ACID;

ANIMALIA; MURINAE;

EID: 0032900836     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199902)24:2<95::AID-GCC1>3.0.CO;2-C     Document Type: Article

References (44)

1. Alexander BI, Rasko JEJ, Morahan G, Cook WD. 1995. Gene deletion explains both in vivo and in vitro generated chromosome 2 aberrations associated with murine myeloid leukemia. Leukemia 9:2009-2015.
2. Bouffler SD, Meijne EIM, Huiskamp R, Cox R. 1996. Chromosomal abnormalities in neutron-induced acute myeloid leukaemias in CBA/H mice. Radiat Res 146:349-352.
3. Bouffler SD, Meijne EIM, Morris DJ, Papworth D. 1997. Chromosome 2 hypersensitivity and clonal development in murine radiation acute myeloid leukaemia. Int J Radiat Biol 72:181-189.
4. Breckon G, Papworth D, Cox R. 1991. Murine radiation myeloid leukaemogenesis: A possible role for radiation-sensitive sites on chromosome 2. Genes Chromosomes Cancer 3:367-375.
5. Buckel A, Beeson D, James M, Vincent A. 1996. Cloning of cDNA encoding human rapsyn and mapping of the RAPSN gene locus to chromosome 11p11.2-p11.1. Genomics 35:613-616.
6. Clark D, Meijne EIM, Bouffler SD, Huiskamp R, Skidmore CJ, Cox R, Silver ARJ. 1996. Microsatellite analysis of recurrent chromosome 2 deletions in acute myeloid leukaemia induced by radiation in F1 hybrid mice. Genes Chromosomes Cancer 16:238-246.
7. Coleman WB, Esch GL, Borchert KM, McCullough KD, Reid LH, Weissman BE, Smith GJ, Grisham JW. 1997. Localization of a putative liver tumor suppressor locus to a 950-kb region of human 11p11.2-p12 using rat liver tumor microcell hybrid cell lines. Mol Carcinog 19:267-272.
8. Copeland NG, Jenkins NA, Gilbert DJ, Eppig JT, Maltais LJ, Miller JC, Dietrich WF, Weaver A, Lincoln SE, Steen RG, Stein LD, Nadeau JH, Lander ES. 1993. A genetic linkage map of the mouse: Current applications and future prospects. Science 262:57-66.
9. Davies NP, Huxley C. 1996. YAC transfer into mammalian cells by cell fusion. In Markie D, editor. Methods in molecular biology, vol 54, VAC protocols. Totowa, N.J.: Humana Press Inc., p 281-292.
10. Dietrich WF, Miller JC, Steen RG, Merchant MA, Damron-Boles D, Husain Z, Dredge R, Daly MJ, Ingalls KA, O'Connor TJ, Evans CA, DeAngelis MM, Levinson DM, Kruglyak L, Goodman N, Copeland NG, Jenkins NA, Hawkins TL, Stein L, Page DC, Lander ESO. 1996. A comprehensive genetic map of the mouse genome. Nature 380:149-152.
11. Dreger RT, Harris MJ, Peichel CL, Vogt TF, Joriloff DM. 1995. The First arch (Far) mutation recombines with Hoxd and Mdk. Mammal Genome 6:662-663.
12. Frail DE, McLaughlin LL, Mudd J, Merlie JP. 1988. Identification of the mouse muscle 43,000-dalton acetylcholine receptor-associated protein (RAPsyn) by cDNA cloning. J Biol Chem 263:15602-15607.
13. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, da Costa LT, Rozenblum E, Weinsrein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE. 1996. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-353.
14. Haldi ML, Strickland C, Lim P, VanBerkel V, Chen XN, Noya D, Korenberg JR, Husain Z, Miller J, Lander ES. 1996. A comprehensive large-insert yeast artificial library for physical mapping of the mouse genome. Mammal Genome 7:767-769.
15. Hayata I. 1983. Partial deletion of chromosome 2 in radiation induced myeloid leukaemia in mice. In: Ishihara T, Sasaki MS, editors. Radiation-induced chromosome damage in man. New York: John Wiley & Sons, p 277-297.
16. Hayata I. 1985. Leukaemogenesis and chromosomal abnormalities: Experimental animals. Acta Haematol Jpn 48:1857-1863.
17. Hayata I, Seki M, Yoshida K, Hirashima F, Sado F, Yamagiwa J, Ishihara T. 1983. Chromosomal aberrations observed in 52 mouse myeloid leukaemias. Cancer Res 43:367-373.
18. Hayata I, Ichikawa T, Ichikawa Y. 1987. Specificity in chromosomal abnormalities in mouse bone marrow induced by the difference of the condition of irradiation. Proc Jpn Acad B 63:289-292.
19. 224Ra of myeloid leukaemia and osteosarcoma in male CBA mice. Int J Radiat Biol 47:239-247.
20. Janknecht R, Nordheim A. 1993. Gene regulation by Tts proteins. Biochim Biophys Acta 1198:346-356.
21. Klemsz MJ, McKercher SR, Celada A, Van Beveren C, Maki RA. 1990. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61:113-124.
22. Lee FS. 1992. Modified protocol for yeast DNA mini-preparation. Biotechniques 12:5.
23. MacGregor TM, Copeland NG, Jenkins NA, Giguere V. 1992. The murine gene for cellular retinoic acid-binding protein type II. J Biol Chem 267:7777-7783.
24. Major IR, Mole RH. 1978. Myeloid leukaemia in X-ray irradiated CBA mice. Nature 272:455-456.
25. Marshall CJ. 1991. Tumor suppressor genes. Cell 64:313-326.
26. McKercher SR, Torbett BE, Anderson KL, Henkel GW, Vestal DJ, Baribault H, Klemsz M, Feeney AJ, Wu GE, Paige CJ, Maki RA. 1996. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J 15:5647-5658.
27. Mitelman F, Mertens F, Johansson B. 1997. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15:417-174.
28. Mole RH, Papworth DG, Corp MJ. 1983. The dose-response for X-ray induction of myeloid leukaemia in male CBA/H mice. Br J Cancer 47:285-291.
29. Moreau-Gachelin F. 1994. Spi-1/PU.1: An oncogene of the Ets family. Biochim Biophys Acta 1198:149-163.
30. Nagira M, Imai T, Ishikawa I, Uwabe KI, Yoshie O. 1994. Mouse homologue of C33 antigen (Cd82), a member of the transmembranc 4 superfamily: complementary DNA, genomic structure, and expression. Cell Immunol 157:144-157.
31. Olopade OI, Buchagen DL, Malik K, Sherman J, Nobori T, Bader S, Nau MM, Gazdar AF, Minna JD, Diaz MO. 1993. Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res 53:2410-2415.
32. Reynolds AB, Herbert L, Cleveland JL, Berg ST, Gaut JR. 1992. p120, a novel substrate of protein tyrosine kinase receptors and of p60v-src, is related to cadherin-binding factors beta-catenin, plakoglobin and armadillo. Oncogene 7:2439-2445.
33. Rithidech KN, Bond VP, Cronkite EP, Thompson MH. 1993. A specific chromosomal deletion in murine leukaemic cells induced by radiation with different qualities. Exp Hematol 21:427-431.
34. Rithidech KN, Bond VP, Cronkite EP, Thompson MH, Bullis JE. 1995. Hypermutability of mouse chromosome 2 during development of X-ray induced murine myeloid leukaemia. Proc Natl Acad Sci USA 92:1152-1156.
35. Scott EW, Simon MC, Anastasi J, Singh H. 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265:1573-1577.
36. Shirakata M, Huppi K, Usuda S, Okazaki K, Yoshida K, Sakano H. 1991. HMG1-related DNA-binding protein isolated with V-(D)-J recombination signal probes. Mol Cell Biol 11:4528-4536.
37. Silver ARJ, Boultwood J, Masson WK, Malowany D, Cox R. 1987. Studies on radiation myeloid leukaemogenesis in the mouse. In Fielden EM, Fowler JF, Hendry JH, Scott D (eds): Radiation Research 2. London: Taylor and Francis, pp 494-500.
38. Siracusa LD, Morgan JL, Fisher JK, Abbot CM, Peters J. 1996. Mouse chromosome 2. Mammal Genome 6:S51-S63.
39. Trakhtenbrot L, Krauthgamer R, Resnitsky P, Haran-Ghera N. 1988. Deletion of chromosome 2 is an early event in the development of radiation induced myeloid leukaemia in SJL/J mice. Leukemia 2:545-550.
40. Van Cong N, Moreau-Gachelin F, Ray D, Gross MS, de Tand MF, Tavitian A, Frezal J. 1989. Assignment of SPI1 oncogene to chromosome 11 (somatic cell hybrid analysis), region p11.22 (in situ hybridization). Cytogenet Cell Genet 51:1097.
41. Van Cong N, Ray D, Gross MS, de Tand MF, Frezall J, Moreau-Gachelin F. 1990. Localization of the human oncogene SPI1 on chromosome 11, region p11.22. Hum Genet 84:542-546.
42. Weinberg RA. 1991. Tumor suppressor genes. Science 254:1138-1146.
43. Weinberg RA. 1995. The molecular basis of oncogenes and tumor suppressor genes. Ann NY Acad Sci 758:331-338.
44. Zoubine MN, Ma JY, Smirnova IV, Citron BA, Festoff BW. 1996. A molecular mechanism for synapse elimination: Novel inhibition of locally generated thrombin delays synapse loss in neonatal mouse muscle. Dev Biol 179:447-457.